Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody-based technologies for target discovery.

Rosaura P C Valle1, Moncef Jendoubi

  • 1Milagen Inc, 770 South 13th Street, Richmond, CA 94804, USA. Valler@milagen.com

Current Opinion in Drug Discovery & Development
|April 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Protein Serum Biomarker Assay for Tracking (Neo)adjuvant and Metastatic Therapy Efficacy and Enabling the Timely Detection of Relapse in Breast Cancer.

Cancers·2025
Same author

New breast cancer marker BF-09 is overexpressed in tumor extracts and secreted in serum.

Biochemistry and biophysics reports·2025
Same author

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.

Disease markers·2004
Same author

New approaches for biomarker discovery in lung cancer.

Expert review of molecular diagnostics·2003
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Antibodies are vital tools in life sciences for target discovery. This review explores their use alongside emerging technologies like mass spectrometry and antibody arrays for identifying new biological targets.

Area of Science:

  • Life Sciences
  • Biotechnology
  • Immunology

Background:

  • Antibodies are established biological products used in diagnostics and therapeutics.
  • Their utility as investigation tools in life sciences is well-recognized.

Purpose of the Study:

  • To review the current applications of antibodies in target discovery.
  • To examine established and emerging technologies that support antibody-driven target discovery.

Main Methods:

  • Review of literature on antibody applications in target discovery.
  • Analysis of technologies including mass spectrometry, protein-protein interaction networks, and antibody arrays.
  • Discussion of antibody engineering and ANTIBIOMIX technology.

Main Results:

Related Experiment Videos

  • Antibodies are versatile tools for identifying and validating biological targets.
  • Emerging technologies significantly enhance the scope and efficiency of antibody-based target discovery.
  • Antibody engineering offers new possibilities for optimizing antibody utility.

Conclusions:

  • Antibodies remain central to target discovery efforts in life sciences.
  • Integration with advanced technologies like mass spectrometry and arrays amplifies their potential.
  • Future directions involve leveraging antibody engineering for novel therapeutic and diagnostic targets.